Carmen Baccarini

417 total citations
18 papers, 195 citations indexed

About

Carmen Baccarini is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Carmen Baccarini has authored 18 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Microbiology and 6 papers in Infectious Diseases. Recurrent topics in Carmen Baccarini's work include Bacterial Infections and Vaccines (11 papers), Pneumonia and Respiratory Infections (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Carmen Baccarini is often cited by papers focused on Bacterial Infections and Vaccines (11 papers), Pneumonia and Respiratory Infections (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Carmen Baccarini collaborates with scholars based in United States, Belgium and Philippines. Carmen Baccarini's co-authors include Andrew Vyse, Jacqueline M. Miller, Yaela Baine, Marie Van der Wielen, Roger Baxter, Ping Li, Igor Smolenov, Donald M. Brandon, Leonard R. Friedland and Véronique Bianco and has published in prestigious journals such as PEDIATRICS, The Lancet Infectious Diseases and Vaccine.

In The Last Decade

Carmen Baccarini

15 papers receiving 189 citations

Peers

Countries citing papers authored by Carmen Baccarini

Since Specialization

Citations

This map shows the geographic impact of Carmen Baccarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Baccarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Baccarini more than expected).

Fields of papers citing papers by Carmen Baccarini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Baccarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Baccarini. The network helps show where Carmen Baccarini may publish in the future.

Co-authorship network of co-authors of Carmen Baccarini

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Baccarini. A scholar is included among the top collaborators of Carmen Baccarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Baccarini. Carmen Baccarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre study 2025 ·EClinicalMedicine ·Michelle Giles, (unknown), Carmen Baccarini, (unknown), (unknown), (unknown), Paul Nguyen, Sachin Kumar Deshmukh, A. Munro Neville, Matthew Hohenboken, (unknown), Huan Jin, Roberto Bugarini, (unknown), Judd L. Walson, Carole Verhoeven, Igor Smolenov	0
2	Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study 2023 ·Vaccine ·Erik Buntinx, (unknown), Charissa Borja-Tabora, Charles Yu, Edison Alberto, (unknown), Josefina Carlos, (unknown), Maya Hites, George R. Siber, Ralf Clemens, Donna M. Ambrosino, (unknown), Huiling Chen, Htay Htay Han, Branda Hu, Ping Li, Carmen Baccarini, Igor Smolenov	10
3	Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study 2023 ·Vaccine ·Romana Hosain, (unknown), Carmen Baccarini, Igor Smolenov, Ping Li, (unknown), Carole Verhoeven, Branda Hu, (unknown), Pilar Rubio	3
4	Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents 2023 ·Human Vaccines & Immunotherapeutics ·Pío López, Lulu Bravo, Erik Buntinx, Charissa Borja-Tabora, Hector Velásquez, (unknown), (unknown), Josefina Carlos, (unknown), Edison Alberto, (unknown), (unknown), Branda Hu, Ping Li, Htay Htay Han, Carmen Baccarini, Igor Smolenov	4
5	Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial 2022 ·The Lancet Infectious Diseases ·Igor Smolenov, Htay Htay Han, Ping Li, Carmen Baccarini, Carole Verhoeven, Frank W. Rockhold, Sue Ann Costa Clemens, Donna M. Ambrosino, Peter Richmond, George R. Siber, Joshua G. Liang, Ralf Clemens	18
6	Safety and Immunogenicity Of A Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered In Healthy Meningococcal Vaccine-Naïve Children (2-9 Years) 2021 ·PEDIATRICS ·(unknown), (unknown), Donald M. Brandon, (unknown), Carmen Baccarini, Emilia Jordanov, Mandeep Singh Dhingra	0
7	Safety and Immunogenicity Of A Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered In Healthy Meningococcal Vaccine-Naïve Children (2-9 Years) 2021 ·(unknown), (unknown), Donald M. Brandon, (unknown), Carmen Baccarini, Emilia Jordanov, Mandeep Singh Dhingra	0
8	Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2–9 Years of Age: A Phase III, Randomized Study 2020 ·The Pediatric Infectious Disease Journal ·Carmen Baccarini, (unknown), Donald M. Brandon, (unknown), Emilia Jordanov, Mandeep Singh Dhingra	17
9	Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study 2019 ·BMC Pediatrics ·Saul N. Faust, (unknown), Chitsanu Pancharoen, M Weber, Katrina Cathie, Ulrich Behre, Jolanta Bernatoniene, Matthew D. Snape, K. von der Helm, (unknown), Ouzama Henry, Carmen Baccarini, Michael Povey, Paul Gillard	3
10	2724. Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Healthy Meningococcal Vaccine-Naïve Children (2–9 Years) 2019 ·Open Forum Infectious Diseases ·(unknown), Donald M. Brandon, (unknown), Carmen Baccarini, Emilia Jordanov, Mandeep Singh Dhingra	2
11	Two-year antibody persistence in children vaccinated at 12–15 months with a measles-mumps-rubella virus vaccine without human serum albumin 2017 ·Human Vaccines & Immunotherapeutics ·Andrea A. Berry, Remon Abu‐Elyazeed, (unknown), Maurice A. Mufson, Christopher J. Harrison, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael Povey, Carmen Baccarini, Bruce L. Innis, Ouzama Henry	7
12	Five-year Antibody Persistence and Booster Response After 1 or 2 Doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children 2016 ·The Pediatric Infectious Disease Journal ·Nicola P. Klein, Yaela Baine, (unknown), Carmen Baccarini, Jacqueline M. Miller, Marie Van der Wielen	16
13	Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults 2015 ·The Pediatric Infectious Disease Journal ·Roger Baxter, Yaela Baine, (unknown), Carmen Baccarini, Jacqueline M. Miller, Marie Van der Wielen	32
14	Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™ 2014 ·Vaccine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mark M. Blatter, Véronique Bianco, Yaela Baine, Leonard R. Friedland, Carmen Baccarini, Jacqueline M. Miller	10
15	10865-year Antibody Persistence and Booster Response to a Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 2014 ·Open Forum Infectious Diseases ·Roger Baxter, Yaela Baine, (unknown), Carmen Baccarini, Jacqueline M. Miller, Marie Van der Wielen	2
16	Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age 2013 ·Journal of the Pediatric Infectious Diseases Society ·Scott A. Halperin, Yaela Baine, Joseph B. Domachowske, Neeraj Aggarwal, (unknown), Joanne M. Langley, Shelly McNeil, Leonard R. Friedland, Véronique Bianco, Carmen Baccarini, Jacqueline M. Miller	20
17	The changing epidemiology of meningococcal disease in North America 1945–2010 2012 ·Human Vaccines & Immunotherapeutics ·Carmen Baccarini, (unknown), (unknown), Andrew Vyse	46
18	Comparison of recovery from postoperative pain utilizing two sling techniques. 2003 ·PubMed ·Victor Hartanto, (unknown), Murali K. Ankem, Carmen Baccarini, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact